Clinical Trials Logo

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

NCT number NCT06349538
Other study ID # 35-435 ex 22/23
Secondary ID
Status Enrolling by invitation
Phase
First received
Last updated
Start date April 4, 2024
Est. completion date April 30, 2034

Study information

Verified date March 2024
Source Medical University of Graz
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The goal of this observational study is to learn about epidemiology, biologic markers, disease subtypes and possible prognostic factors in essential tremor (ET) patients. The main question[s] it aims to answer are: - The prevalence of ET-plus compared to ET in a prospectively collected ET population. - To assess in detail the heterogenous group of ET patients using comprehensive clinical (motor and non-motor scales, questionnaires), imaging [magnetic resonance imaging (MRI), sonography of substantia nigra and cerebral vessels], neurophysiological (tremor analysis, digital spiral drawing) and laboratory markers (sGFAP, sNfL, routine laboratory parameters). - To assess possible non-invasive markers of neurodegeneration in ET patients (optic coherence tomography, alpha-synuclein in olfactory mucosa) Participants will be asked to undergo the above mention evaluation at baseline and at follow-up approx. 5 years later. Researchers will compare the findings within the ET group to independently existing cohorts of healthy controls and/or patients with other movement disorders like Parkinson's disease.


Recruitment information / eligibility

Status Enrolling by invitation
Enrollment 100
Est. completion date April 30, 2034
Est. primary completion date April 30, 2026
Accepts healthy volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Presence of an essential tremor syndrome according to MDS consensus criteria or suspected incipient essential tremor (differential diagnosis vs. enhanced physiological tremor) - Patient is able and willing to give informed consent. - age above 18 years. Exclusion Criteria: - Patient is not able or not willing to give informed consent. - Existence of a legal representative. - age below 18 years

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
Clinical examination, blood draw, cerebral MRI, sonography, tremor analysis, OCT, olfactory mucosa swab.
see previous descriptions

Locations

Country Name City State
Austria Medical University of Graz Graz

Sponsors (1)

Lead Sponsor Collaborator
Medical University of Graz

Country where clinical trial is conducted

Austria, 

References & Publications (3)

Bhatia KP, Bain P, Bajaj N, Elble RJ, Hallett M, Louis ED, Raethjen J, Stamelou M, Testa CM, Deuschl G; Tremor Task Force of the International Parkinson and Movement Disorder Society. Consensus Statement on the classification of tremors. from the task force on tremor of the International Parkinson and Movement Disorder Society. Mov Disord. 2018 Jan;33(1):75-87. doi: 10.1002/mds.27121. Epub 2017 Nov 30. — View Citation

Doustar J, Torbati T, Black KL, Koronyo Y, Koronyo-Hamaoui M. Optical Coherence Tomography in Alzheimer's Disease and Other Neurodegenerative Diseases. Front Neurol. 2017 Dec 19;8:701. doi: 10.3389/fneur.2017.00701. eCollection 2017. — View Citation

Stefani A, Iranzo A, Holzknecht E, Perra D, Bongianni M, Gaig C, Heim B, Serradell M, Sacchetto L, Garrido A, Capaldi S, Sanchez-Gomez A, Cecchini MP, Mariotto S, Ferrari S, Fiorini M, Schmutzhard J, Cocchiara P, Vilaseca I, Brozzetti L, Monaco S, Jose Marti M, Seppi K, Tolosa E, Santamaria J, Hogl B, Poewe W, Zanusso G; SINBAR (Sleep Innsbruck Barcelona) group. Alpha-synuclein seeds in olfactory mucosa of patients with isolated REM sleep behaviour disorder. Brain. 2021 May 7;144(4):1118-1126. doi: 10.1093/brain/awab005. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Prevalence of ET-plus Determine the prevalence of ET-plus within a prospectively collected ET population approx. 2 years
Secondary Age of ET patients age at disease onset and age at baseline 1 minute; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline)
Secondary Sex of ET patients male, female, other 1 minute; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline)
Secondary Family history positive or negative for essential tremor or Parkinson's disease 1 minute; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline)
Secondary Symptom leading to ET-plus classification e.g. rest tremor, impaired tandem gait, mild parkinsonian signs, questionable dystonia, mild cognitive impairment 1 minute; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline)
Secondary current and former medication for essential tremor e.g. propranolol yes vs no, topiramate yes vs no, primidone yes vs no 2 minutes; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline)
Secondary subjective disease course of ET no progression, slowly and continuously, relapsing, plateau-like after initial progression, rapidly progressive 1 minute; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline)
Secondary responsivity to alcohol amelioration of tremor severity after consumption of alcohol (yes vs. no vs. unknown) 1 minutes; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline)
Secondary presence of cardiovascular risk factors arterial hypertension yes vs. no, hyperlipidemia yes vs. no, smoking yes vs. no vs. former, diabetes mellitus yes vs. no, coronary artery disease yes vs. no 2 minutes; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline)
Secondary MDS-UPDRS (Movement Disorder Society Unified Parkinson's Disease Rating Scale) parts I-IV rates clinical severity of parkinsonian symptoms, range 0-260 points with higher points meaning more severe symptoms 20-30 minutes; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline)
Secondary modified Essential Tremor Rating Assessment Scale (mTETRAS) rates clinical severity of ET symptoms, ranging from 0-80 (the "modified" means the inclusion of 2 additional items rating rest tremor) with higher points meaning more severe motor symptoms; also includes a subscale rating activities of daily living ranging from 0-48 points with more points meaning more severe disability due to ET 10 minutes; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline)
Secondary Scale for the assessment and rating of ataxia (SARA) assesses symptoms of ataxia, ranging from 0 (no ataxia) to 40 (most severe ataxia) 5-10 minutes; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline)
Secondary Verbal fluency animals (part of the CERAD-plus test battery) patients needs to say as many animals as possible within 1 minute, the more, the better 1 minute; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline)
Secondary Boston Naming Test (part of the CERAD-plus test battery) the patient needs to name 15 items (shown as pictures) correctly, the more, the better 2 minutes; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline)
Secondary Mini Mental State Examination Test (MMSE; part of the CERAD-plus test battery) a cognitive screening test with a minimum of 0 and a maximum of 30 points 3-5 minutes; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline)
Secondary word list learning (part of the CERAD-plus test battery) the patient is shown 10 words which he needs to remember and repeat immediately after reading them (within 90 seconds); there a three tries; the more he remembers, the better 10 minutes; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline)
Secondary constructive praxis (part of the CERAD-plus test battery) the patient needs to draw 4 figures from a model which are then rated according to prespecified criteria (maximum of 11 points, the more the better) 20-30 minutes; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline)
Secondary word list recall (part of the CERAD-plus test battery) the patient needs to remember as many of the 10 words learned in "word list learning"; time limit 90 seconds 90 seconds; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline)
Secondary word list recognition (part of the CERAD-plus test battery) the patient needs decide whether a word shown to him was part of the 10 words learned before; there a 20 words in total, and 10 each were part of the learned words while 10 where not; the more he/she remembers correctly, the better (1 point for each correctly identified word) 2 minutes; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline)
Secondary constructive praxis recall (part of the CERAD-plus test battery) the patients needs to draw the 4 figures from "constructive praxis" from memory; they are then rated according to the same criteria with a maximum of 11 points 3-4 minutes; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline)
Secondary Trail Making Test A (part of the CERAD-plus test battery) the patient needs to connect numbers in ascending order from 1 to 25, time is measured in seconds (the faster, the better) 2 minutes; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline)
Secondary Trail Making Test B (part of the CERAD-plus test battery) the patient needs to connect numbers and letters in ascending and alternating order from 1 to 13 and A to L, respectively, time is measured in seconds (the faster, the better) 2 minutes; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline)
Secondary s-words (part of the CERAD-plus test battery) the patient needs to list as many words starting with the letter "s" within 60 seconds as possible; the more the better 1 minute; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline)
Secondary Frontal Assessment Battery (FAB) a neuropsychological test focusing on executive function, ranging from 0 (most impaired) to 18 (normal) 5 - 10 minutes; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline)
Secondary Geriatric Depression Scale (GDS) a short questionnaire rating depressive symptoms, ranging from 0 (no depressive symptoms) to 15 (most severe depressive symptoms) 3-5 minutes; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline)
Secondary Hospital Anxiety and Depression Scale (HADS) a questionnaire rating anxiety and depressive symptoms, ranging from 0 (no depressive/anxious symptoms) to 42 (most severe symptoms) 5 minutes; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline)
Secondary Non-Motor Symptoms Scale for Parkinson's Disease (NMSS) a questionnaire rating non motor symptoms, ranging from 0 (no symptoms) to 128 (most severe non motor symptoms) 5 minutes; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline)
Secondary RBD Screening Questionnaire rates probability for the presence of RBD (REM sleep behavior disorder) using 13 questions; points are given from 0 to 13 with higher points indicating a higher probability for RBD 2 minutes; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline)
Secondary Global Physical Activity Questionnaire (GPAQ) the GPAQ is a questionnaire provided by the WHO and rates the extent of physical (-in-) activity; rating is done according to the WHO manual available from the WHO website 5-7 minutes; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline)
Secondary Quality of Life in Essential Tremor Questionnaire (QUEST) a questionnaire rating quality of life specifically in ET patients; ranging from 0 (best quality of life) to 120 points (worst quality of life) 5 minutes; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline)
Secondary University of Pennsylvania Smell Identification Test (UPSIT) a smell test ranging from 0 (worst olfactory function) to 40 points (best olfactory function) 10-15 minutes; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline)
Secondary Montreal Cognitive Assessment (MOCA) a screening cognitive test rating cognitive dysfunction from 0 (worst) to 30 (best) 5-10 minutes; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline)
Secondary Auditory verbal learning test assesses how well patients can remember 15 words after hearing them; the more they can remember, the better 5 minutes; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline)
Secondary Symbol Digit Modalities Test (SDMT) patients need to translate specific symbols into numbers (1-9) using a key; they more the can translate in 90 seconds, the better 90 seconds; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline)
Secondary Brief Visuospatial Memory Test patients can look at 6 figures for 10 seconds each, then they have to reproduce them; 3 trials; the more they remember, the better 2-3 minutes; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline)
Secondary Comprehensive trail making test 4 patients have to connect numbers (1 to 21) in ascending order with lines; time is measured in seconds; the faster, the better 1-2 minutes; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline)
Secondary Comprehensive trail making test 5 patients have to connect numbers (1 to 13) and letters (A to L) in ascending order and alternatingly with lines; time is measured in seconds; the faster, the better 1-2 minutes; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline)
Secondary Regensburg word fluency test patients have to list words starting with "g" or "r" alternatingly or things within the categories of "clothes" or "flowers" alternatingly; they have 1 minute for each of the two tasks, the more they can list, the better 2 minutes; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline)
Secondary EQ-5D a quick questionnaire (5 questions) rating quality of life, ranging from 0 (very bad) to 1 (best) 1-2 minutes; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline)
Secondary resilience scale (RS-13) a quick questionnaire rating resilience, ranging from 13 (least resilience) to 91 points (highest resilience) 1-2 minutes; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline)
Secondary Pittsburgh Sleep Quality Index (PSQI) a quick questionnaire rating sleep quality, ranging from 0 (best sleep) to 21 points (worst sleep quality) 3-4 minutes; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline)
Secondary Digital Spiral Drawing patients are asked to draw Archimedes spirals (a total of 4, 2 with each hand) on a standard tablet PC using a touchpen; the process is done using a free available website-based application (http://www.trsper.com/); the main outcome is visual rating of the spirals ranging from 0 (perfectly normal) to 9 (worst spiral) 2-3 minutes; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline)
Secondary Schellong Test blood pressure test for orthostatic hypotension; blood pressure is measured non-invasively using a automatic device at the left arm in seating position and after 1 and 3 minutes of standing; orthostatic hypotension is defined as a drop in systolic blood pressure of 20mmHg or more and/or of diastolic blood pressure of 10mmHg or more 3.5 minutes; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline)
Secondary serum glial fibrillary acidic protein (sGFAP) sGFAP-level is measured from serum using SIMOA-technology 5 minutes; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline)
Secondary serum neurofilament light (sNfL) sNfL-level is measured from serum using SIMOA-technology 5 minutes; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline)
Secondary Transcranial sonography the presence of hyperechogenicity (yes/no and area in cm2) of the substantia nigra is measured using transcranial sonography 10 minutes; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline)
Secondary tremor analysis tremor frequency and total tremor power are measured 20 minutes; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline)
Secondary cerebral MRI white matter hyperintensities (volume in mm3) 45 minutes; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline)
Secondary cerebral MRI presence of lacunes (number of) 45 minutes; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline)
Secondary cerebral MRI cerebral microbleeds (number of) 45 minutes; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline)
Secondary cerebral MRI volumetry of total brain and regions (in mm3) 45 minutes; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline)
Secondary cerebral MRI Diffusion tensor imaging parameters (fractional anisotropy, mean diffusivity, radial diffusivity) 45 minutes; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline)
Secondary cerebral MRI nigrosome-1-imaging (presence of swallow tail sign yes vs. no) 45 minutes; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline)
Secondary optic coherence tomography (OCT) thickness of retinal nerve fiber layer in both eyes and each quadrant and in vicinity of the macula and papilla 5-10 minutes; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline)
Secondary optic coherence tomography (OCT) thickness of ganglion cell layer in both eyes and each quadrant and in vicinity of the macula and papilla 5-10 minutes; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline)
Secondary optic coherence tomography (OCT) thickness of inner plexiform layer in both eyes and each quadrant and in vicinity of the macula and papilla 5-10 minutes; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline)
Secondary optic coherence tomography (OCT) thickness of choroidea in both eyes and each quadrant and in vicinity of the macula and papilla 5-10 minutes; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline)
Secondary Olfactory mucosa swab swab of the olfactory mucosa testing for alpha-synuclein using a seeding assay (outcome: presence of misfolded alpha-synuclein yes vs. no) 5-10 minutes; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline)
See also
  Status Clinical Trial Phase
Withdrawn NCT05381688 - VIM DBS Respiratory Modulation: N-of-1 Trial
Recruiting NCT05101161 - Neurofeedback Using Implanted Deep Brain Stimulation Electrodes N/A
Completed NCT02277106 - Evaluate SAGE-547 in Participants With Essential Tremor Phase 2
Recruiting NCT05769933 - Bridging Gaps in the Neuroimaging Puzzle: New Ways to Image Brain Anatomy and Function in Health and Disease Using Electroencephalography and 7 Tesla Magnetic Resonance Imaging
Terminated NCT02894567 - Evaluation of Directional Recording and Stimulation Using spiderSTN N/A
Terminated NCT02678429 - Atlas Predicted DBS Settings in Essential Tremor N/A
Completed NCT02523807 - Tremor Monitoring Device N/A
Active, not recruiting NCT02255929 - Gamma Knife Radiosurgery for Treatment of Essential Tremor N/A
Completed NCT01223144 - Decision-making and Emotion Recognition in Essential Tremor N/A
Completed NCT00906412 - Ventrointermediate Nucleus (VIM DBS) and Working Memory N/A
Recruiting NCT05214222 - Penpulimab Plus Chemotherapy With/Without Anlotinib for Patients With Advanced Esophageal Squamous Cell Carcinoma Phase 2
Completed NCT03051178 - Wearable Sensor for Responsive DBS for ET N/A
Recruiting NCT03795935 - Relief From Side Effects: Clinical Use of Electrodes With Direction N/A
Not yet recruiting NCT06036368 - Study to Evaluate Safety and Efficacy of Peroneal Transcutaneous NeuroModulation in Subjects With Parkinson's Disease and Essential Tremor N/A
Recruiting NCT05897775 - Coordinated Reset Deep Brain Stimulation for Essential Tremor Phase 1
Recruiting NCT05968976 - Multicentre RCT of Awake Versus Asleep Tractography Based DBS for ET N/A
Completed NCT06314139 - Tolerability and Efficacy of Continuous Theta-burst Stimulation for Essential Tremor: A Randomized Study. N/A
Recruiting NCT04501133 - Sensory-specific Peripheral Stimulation for Tremor Management N/A
Active, not recruiting NCT03560622 - Functional Neuroimaging Feedback for Focused Ultrasound Thalamotomy N/A
Completed NCT00368199 - Transcranial Duplex Scanning and Single Photon Emission Computer Tomography (SPECT) in Parkinsonian Syndromes N/A